Validation of an Integrated Somatic and Epigenomic Circulating Tumor DNA Assay using Blood Samples from Patients with Resectable Locally Advanced Rectal Cancer
Not Applicable
- Conditions
- Resectable Locally Advanced Rectal Cancer
- Registration Number
- JPRN-UMIN000040151
- Lead Sponsor
- ational Cancer Center Hospital East
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 55
Inclusion Criteria
Not provided
Exclusion Criteria
1. Pregnant. 2. Judged by the study doctor to be ineligible for the study for any other reason.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Positive rate of LUNAR assay
- Secondary Outcome Measures
Name Time Method Correlation between post-operative positive rate of LUNAR assay and prognosis Correlation between status of LUNAR assay and efficacies of VOLTAGE treatment Concordance of gene status between LUNAR assay and tumor tissue Concordance of MSI status between LUNAR assay and tumor tissue Correlation between microbiome and the efficacies of the VOLTAGE study